Drugs / NZ MenB OMV vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00774384 Comparator | Sep 2009 → Nov 2011 | meningococcal infection | University Hospitals Bristol and Weston NHS Foundation Trust | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NZ MenB OMV vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00774384 ↗ |
| Known as | NZ98/254 | “NZ MenB OMV vaccine (NZ98/254)” NCT00774384 ↗ |
| Modality | Vaccine | “MenB vaccine” NCT00774384 ↗ |
| Route | Intramuscular | “3 doses by intramuscular injection” NCT00774384 ↗ |